Stenting in Non-Small Cell Lung Cancer: How Does It Affect the Outcomes?

Area of Science:

• Pulmonology
• Oncology
• Interventional Pulmonology

Background:

• Central airway obstruction (CAO) affects approximately 30% of lung cancer patients, significantly impacting survival.
• Limited data exists on the benefits of stenting for heterogeneous CAO patient groups.

Purpose of the Study:

• To compare overall survival (OS) and hospitalization risk in lung cancer patients with CAO, stratified by the need for stent placement.
• To evaluate the impact of interventional pulmonology (IP) consultation on outcomes for advanced non-small cell lung cancer (NSCLC) patients with CAO.

Main Methods:

• Retrospective chart review of 171 NSCLC patients undergoing bronchoscopy (2011-2013).
• Analysis focused on 25 advanced NSCLC patients evaluated for endobronchial stenting for CAO, comparing 17 who received stents with 8 who did not.
• Demographic data, hospitalization rates, and OS were assessed.

Main Results:

• Patients requiring stent placement for CAO had significantly higher odds of hospitalization (OR: 15.913, P = 0.0352) compared to those not needing stents.
• Overall survival was shorter for patients with CAO requiring stenting (13.9 months) versus those not requiring stents (23.9 months).
• Less severe CAO correlated with lower hospitalization rates and better OS.

Conclusions:

• Interventional pulmonology evaluation and management may improve overall survival for advanced NSCLC patients with CAO.
• IP consultation could enhance both quality of life and survival for these patients.